<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02264600</url>
  </required_header>
  <id_info>
    <org_study_id>AWED-31014</org_study_id>
    <nct_id>NCT02264600</nct_id>
  </id_info>
  <brief_title>Apelin in Willis Ekbom Disease</brief_title>
  <official_title>Oxidative Stress and Apelin Level in Willis Ekbom Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Acibadem University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Acibadem University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess apelin level in patients with Willis-Ekbom Disease
      (WED) as known Restless Legs Syndrome (RLS). Cardiovascular complications of WED have been
      reported in recent studies. Increased oxidative stress is thought to play an important role
      in cardiovascular complications of WED patients. Apelin is a novel described antioxidant
      bioactive peptide. The investigators hypothesize that patients with WED have lower plasma
      apelin level than healthy subjects based on presence of oxidative stress of WED.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>2 Days</target_duration>
  <primary_outcome>
    <measure>Serum apelin level in WED patients and healthy controls</measure>
    <time_frame>Two months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Restless Legs Syndrome</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are administered to Kayseri Acibadem Hospital Sleep Medicine Unit, outpatient
        clinic.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients diagnosed as RLS/WED according to International Classification of Sleep
             Disorders (ICSD-3) criteria

          -  Patients with idiopathic RLS/WED

          -  Moderate and severe RLS/WED according to International Restless Legs Syndrome Rating
             Scale

          -  Periodic Leg Movements Index above 5 in polysomnography record

          -  BMI below 25

        Exclusion Criteria:

          -  Disorders which cause symptomatic RLS(Iron deficiency anemia, kidney failure, diabetes
             mellitus, pregnancy, Parkinson's disease, multiple sclerosis, neuropathy)

          -  Systemic diseases which cause possible oxidative stress status (cardiovascular
             diseases, obesity, diabetes mellitus, use of any medical drugs especially ACE
             inhibitors e.g.)

          -  Another sleep disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Murat Aksu, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Acibadem University Faculty of Medicine, School of Electroneurophysiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Selda Korkmaz, Assist. Prof. Dr.</last_name>
    <phone>00905325807889</phone>
    <email>korkmazs78@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tugce Bilecenoglu, M.D.</last_name>
    <phone>00905386275515</phone>
    <email>nedimetugche@yahoo.com</email>
  </overall_contact_backup>
  <link>
    <url>http://www.rls.org</url>
  </link>
  <link>
    <url>http://www.sciencedirect.com</url>
  </link>
  <reference>
    <citation>Cikrikcioglu MA, Hursitoglu M, Erkal H, Kınas BE, Sztajzel J, Cakirca M, Arslan AG, Erek A, Halac G, Tukek T. Oxidative stress and autonomic nervous system functions in restless legs syndrome. Eur J Clin Invest. 2011 Jul;41(7):734-42. doi: 10.1111/j.1365-2362.2010.02461.x. Epub 2011 Jan 20.</citation>
    <PMID>21250984</PMID>
  </reference>
  <reference>
    <citation>Baskol G, Korkmaz S, Erdem F, Caniklioglu A, Kocyigit M, Aksu M. Assessment of nitric oxide, advanced oxidation protein products, malondialdehyde, and thiol levels in patients with restless legs syndrome. Sleep Med. 2012 Apr;13(4):414-8. doi: 10.1016/j.sleep.2011.11.012.</citation>
    <PMID>22469072</PMID>
  </reference>
  <reference>
    <citation>Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpéné C, Audigier Y, Saulnier-Blache JS, Valet P. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005 Apr;146(4):1764-71. Epub 2005 Jan 27.</citation>
    <PMID>15677759</PMID>
  </reference>
  <reference>
    <citation>Lv SY, Qin YJ, Wang HT, Xu N, Yang YJ, Chen Q. Centrally administered apelin-13 induces depression-like behavior in mice. Brain Res Bull. 2012 Sep 1;88(6):574-80. doi: 10.1016/j.brainresbull.2012.06.003. Epub 2012 Jun 21.</citation>
    <PMID>22728209</PMID>
  </reference>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 3, 2014</study_first_submitted>
  <study_first_submitted_qc>October 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2014</study_first_posted>
  <last_update_submitted>October 10, 2014</last_update_submitted>
  <last_update_submitted_qc>October 10, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 15, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Acibadem University</investigator_affiliation>
    <investigator_full_name>Selda Korkmaz</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Restless Legs Syndrome, Apelin, Oxidative Stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
    <mesh_term>Restless Legs Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

